Online citations, reference lists, and bibliographies.
← Back to Search

Lack Of Association Between Apolipoprotein E Polymorphism And Vascular Dementia In Koreans

Ki Woong Kim, J. Youn, Moon‐Ku Han, Nam Jong Paik, Tae Joo Lee, Joon Hyuk Park, Seok Bum Lee, Il Han Choo, Dong Young Lee, Jin Hyeong Jhoo, Jong Inn Woo
Published 2008 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
To investigate an association of vascular dementia (VD) with the apolipoprotein E (APOE) polymorphism, the APOE polymorphism of 100 VD patients, 100 age- and gender-matched Alzheimer disease (AD) patients, and 200 age- and gender-matched nondemented control (NC) subjects was genotyped. The distribution of APOE polymorphism was compared. Neither the APOE ε4 allele nor the APOE ε2 allele was more prevalent in the VD patients compared with the NC subjects (P > .1 by the χ 2 test), which was the case when both men and women were analyzed separately (P > .1 by the χ2 test) and when young patients (75 years old or less) and old patients (more than 75 years old) were analyzed separately (P > .1 by the χ2 test). The estimated statistical power was over 0.80 when the odds ratios (OR) for VD conferred to the APOE ε4 are assumed to be higher than 2.2 and the type I error probability is set at 0.05, which is much higher than the power of the previous studies on the VD/APOE association. In conclusion, the results suggested that APOE ε4 allele does not confer the risk for VD, and even if it does, it does so very modestly.
This paper references
10.1002/ANA.410070516
Pathological verification of ischemic score in differentiation of dementias
W. Rosen (1980)
10.1192/BJP.140.6.566
A new clinical scale for the staging of dementia.
C. P. Hughes (1982)
10.1161/01.ATV.8.1.1
Apolipoprotein E polymorphism and atherosclerosis.
J. Davignon (1988)
10.1093/IJE/20.3.736
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group.
A. Hofman (1991)
10.1212/WNL.42.1.115
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study
D. Bachman (1992)
10.1212/WNL.43.2.250
Vascular dementia
G. C. Román (1993)
10.1159/000106730
Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia
G. Frisoni (1994)
10.1097/00001756-199410000-00013
Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia.
C. Bétard (1994)
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia.
G. Frisoni (1994)
10.1136/jnnp.57.11.1414
Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.
J. Kawamata (1994)
Apolipopro - teine genotype influences amyloid deposition and limbic neurofibrillary degeneration , but not Lewy body or vascular pathologies in postmortem brains
DW Dickson (1994)
10.1001/JAMA.1995.03520290026015
Apolipoprotein E E4 allele and risk of dementia.
A. Roses (1995)
10.1161/01.STR.26.5.743
Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
O. Kosunen (1995)
10.1111/j.1600-0404.1995.tb00132.x
Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men
J. Stengård (1995)
10.1111/j.1600-0404.1996.tb00008.x
The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia
T. Pirttilä (1996)
10.1097/00002093-199601040-00003
APOE-ε4 in Patients with Alzheimer Disease and Vascular Dementia
T. Treves (1996)
APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.
T. Treves (1996)
Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy.
S. Greenberg (1996)
10.1111/j.1399-0004.1996.tb02712.x
The apolipoprotein E gene in Binswanger's disease and vascular dementia
S. Higuchi (1996)
10.1212/WNL.46.3.673
Apolipoprotein E element 4 association with dementia in a population-based study
R. Myers (1996)
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
R. Myers (1996)
The frequency of apolipoprotein E 4 allele is not increased in patients with probable vascular demen
T Pirttila (1996)
10.1001/JAMA.278.16.1349
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
L. Farrer (1997)
10.1016/S0197-2456(97)00074-3
PS power and sample size program available for free on the internet
W. Dupont (1997)
10.1001/JAMA.277.10.818
Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
A. Slooter (1997)
10.1212/WNL.49.3.779
Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia
R. Katzman. (1997)
10.1001/JAMA.1997.03550160069041
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis
L. Farrer (1997)
10.1111/j.1399-0004.1997.tb04362.x
Apolipoprotein E type ε4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia
A. L. Bergem (1997)
10.1016/S0304-3940(97)00538-7
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients
B. Palumbo (1997)
10.1016/S0021-9150(98)00105-1
The relationship between apolipoprotein E, dementia, and vascular illness.
D. Marin (1998)
10.1097/00002093-199809000-00002
Prevalence and Subtypes of Dementia in a Rural Chinese Population
H. Liu (1998)
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
I. Notkola (1998)
10.1159/000017068
Apolipoprotein E Polymorphism in Patients with Alzheimer’s Disease, Vascular Dementia and Ischemic Cerebrovascular Disease
Y. Ji (1998)
10.1159/000017074
Epidemiologic and Genetic Studies of Dementia of the Alzheimer Type in Japan
K. Urakami (1998)
10.1111/j.1600-0404.1998.tb07288.x
Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population
J. Kalman (1998)
10.1046/j.1440-1819.1999.00619.x
Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer’s disease and vascular dementia in Mie Prefecture of Japan
S. Nakayama (1999)
10.1016/S0304-3940(99)00867-8
Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans
Ki Woong Kim (1999)
Apolipopro - tein - e genotype influences amyloid deposition and limbic neurofibrillary degeneration , but not Lewy body or vascular pathologies in postmortem brains
DW Dickson (1999)
Apolipoprotein-e genotype influences amyloid deposition and limbic neurofibrillary degeneration, but not Lewy body or vascular pathologies in postmortem
DW Dickson (1999)
10.1159/000017245
Apolipoprotein E and Intronic Polymorphism of Presenilin 1 and Alpha-1-Antichymotrypsin in Alzheimer’s Disease and Vascular Dementia
T. Rodriguez Martin (2000)
10.3892/IJMM.7.2.217
Is ApoE gene a risk factor for vascular dementia in Han Chinese?
J. Yang (2001)
10.1002/GPS.330
Apolipoprotein E ϵ4 allele is a risk factor for late‐onset Alzheimer's disease and vascular dementia in Han Chinese
J. Zhang (2001)
10.1016/S0304-3940(01)01911-5
Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-ε4 allele in Latin Americans: findings from the Maracaibo Aging Study
A. Molero (2001)
10.1093/GERONB/57.1.P47
Development of the Korean Version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K)Clinical and Neuropsychological Assessment Batteries
Jung Hie Lee (2002)
10.1016/S0022-510X(02)00286-1
APOE genotype in cerebrovascular disease and vascular dementia
A. Frank (2002)
10.1016/S0022-510X(02)00287-3
Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease
L. Traykov (2002)
10.2337/DIABETES.51.4.1256
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.
R. Peila (2002)
Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
L. Traykov (2002)
10.1046/j.1532-5415.2002.50310.x
The Prevalence of Dementia in Older People in an Urban Population of Korea: The Seoul Study
D. Y. Lee (2002)
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia
R Peila (2002)
, APOE gene , and the risk for dementia and related pathologies : the Honolulu - Asia Aging Study
CL Lai (2002)
Type 2 diabetes , APOE gene , and the risk for dementia and related pathologies : the HonoluluAsia Aging Study
R Peila (2002)
10.1136/jnnp.74.8.1148
Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects
S. Engelborghs (2003)
10.1159/000072804
Apolipoprotein E in Taiwan Chinese Patients with Dementia
C. Lai (2003)
10.1016/S0022-510X(03)00026-1
Apolipoprotein E, angiotensin-converting enzyme and  α-1-antichymotrypsin genotypes are not associated with post-stroke dementia
A. Arpa (2003)
10.1159/000076345
Apolipoprotein E Gene Polymorphism in Indian Patients with Alzheimer’s Disease and Vascular Dementia
K. Luthra (2004)
10.3892/IJMM.14.4.609
Apolipoprotein E as vascular risk factor in neurodegenerative dementia.
M. Folin (2004)
10.1159/000075956
Apolipoprotein E Polymorphism in Ischemic Cerebrovascular Diseases and Vascular Dementia Patients in Taiwan
Hsiu-Fen Lin (2004)
The gender- and agedependency of the risk for Alzheimer’s disease conferred to apolipoprotein E polymorphism in Koreans
JH Jhoo (2004)
Type 2
R Peila



This paper is referenced by
10.21767/2171-6625.1000224
Latin American Delphi Consensus on Vascular Cognitive Impairment: Definitions, Clinical Features, Pathophysiology, Prevention and Treatment
A. M. Alvarado (2017)
10.1097/YPG.0000000000000126
Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer’s disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China
K. Chen (2016)
10.12779/DND.2015.14.2.70
A Comparison of Apolipoprotein E Polymorphism in Alzheimer's Disease and Subcortical Vascular Dementia in Koreans
J. W. Kim (2015)
10.1016/j.archger.2014.11.006
Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence of dementia and cognitive impairment in a population of 70-74-year olds: the InveCe.Ab study.
A. Guaita (2015)
10.3233/JAD-143102
Genetics of Vascular Dementia: Systematic Review and Meta-Analysis.
Jia-Hao Sun (2015)
10.1016/B978-0-12-799961-6.00008-1
The Epidemiology and Genetics of Vascular Dementia: Current Knowledge and Next Steps
A. Naj (2015)
Apolipoprotein E pathology in vascular dementia.
T. Rohn (2014)
Original Article Apolipoprotein E pathology in vascular dementia
Troy T. Rohn (2014)
10.4236/AAR.2014.33029
The Relation between Apolipoprotein E4 Genotype and Vascular Dementia
Tomader Taha Abdel Rahman (2014)
Is apolipoprotein E4 an important risk factor for vascular dementia?
T. Rohn (2014)
10.2174/1567205011666141001123356
Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China
S. Zhou (2014)
Association Healthcare Professionals From the American Heart Association/American Stroke Vascular Contributions to Cognitive Impairment and Dementia : A Statement for
H. Chui (2013)
10.1097/WCO.0b013e32835c4f04
Vascular cognitive impairment.
F. Rincon (2013)
10.3233/JAD-121069
Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment.
Rebecca Dwyer (2013)
10.1161/STROKEAHA.112.651778
Prevention of vascular cognitive impairment.
M. Dichgans (2012)
10.1159/000337025
Apolipoprotein E Gene Polymorphism in a Chinese Population with Vascular Dementia: A Meta-Analysis
B. Liu (2012)
10.1016/j.neulet.2012.02.031
Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis
Yan-wei Yin (2012)
10.1159/000343789
Plasma Levels of Apolipoprotein E and Risk of Intracranial Artery Stenosis in Acute Ischemic Stroke Patients
Yong-Jae Kim (2012)
10.1159/000335494
Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia
H. G. Ryu (2012)
AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia
P. Gorelick (2011)
10.1161/STR.0b013e3182299496
Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
P. Gorelick (2011)
10.1097/YPG.0b013e328341e051
Genetic dissection of susceptibility to vascular dementia
Younyoung Kim (2011)
10.1007/s00702-011-0714-6
ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis
X. Liu (2012)
for Healthcare Professionals From the American Heart Association/American Vascular Contributions to Cognitive Impairment and Dementia : A Statement
P. Nilsson (2011)
10.3233/JAD-2011-101611
APOE ε4 allele status in korean dementia patients with severe white matter hyperintensities.
Y. Hong (2011)
10.1016/S1474-4422(10)70325-2
Apolipoprotein E in Alzheimer's disease and other neurological disorders
P. Verghese (2011)
10.1159/000285166
Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study
Y. Chuang (2010)
Apoe epsilon4 allele frequency in patients with dementia in different ethnic and geographic groups
D. Aslan (2010)
10.1097/WAD.0b013e318190a855
The Effect of APOE-ϵ4 on Dementia is Mediated by Alzheimer Neuropathology
J. Mortimer (2009)
Cholesterol and late-life cognition. An epidemiological and clinical approach
Alina Solomon (2009)
Perfil genético do ApoE na Demência Genetic profiling of ApoE in Dementia
L. P. Rodrigues ()
Semantic Scholar Logo Some data provided by SemanticScholar